Jin Medical International Cash Flow Statement (2022-2025) | ZJYL

Cash Flow Statement Sep2022 Mar2023 Sep2023 Mar2024 Sep2024 Mar2025
Operating Activities
Gains from Sales and Divestitures (Quarter) 523.000.00M
Change in Working Capital
Change in Receivables (Quarter) 0.25M0.29M0.95M1.52M2.55M1.39M
Change in Inventory (Quarter) 6.72M6.51M5.05M4.54M5.17M4.46M
Change in Account Payables (Quarter) 4.11M4.61M3.39M3.15M3.01M3.06M
Change in Accured Expenses (Quarter) 0.39M0.38M0.32M0.53M0.43M0.45M
Change in Taxes (Quarter) 0.25M0.34M0.27M0.56M1.12M0.61M